205 related articles for article (PubMed ID: 30081924)
1. Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinoma.
Xiao T; Zhang Q; Zong S; Zhong WL; Qin Y; Bi Z; Chen S; Liu HJ; Wei JJ; Zhou BJ; Wang LM; Zhou HG; Liu YR; Sun T; Yang C
J Exp Clin Cancer Res; 2018 Aug; 37(1):185. PubMed ID: 30081924
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia induced epithelial-mesenchymal transition and vasculogenic mimicry formation by promoting Bcl-2/Twist1 cooperation.
Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
Exp Mol Pathol; 2015 Oct; 99(2):383-91. PubMed ID: 26318343
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma.
Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Liu T; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
Int J Mol Med; 2015 Sep; 36(3):783-91. PubMed ID: 26202447
[TBL] [Abstract][Full Text] [Related]
4. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
5. Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma.
Wang Y; Sun B; Zhao X; Zhao N; Sun R; Zhu D; Zhang Y; Li Y; Gu Q; Dong X; Wang M; An J
Oncotarget; 2016 Apr; 7(17):24383-401. PubMed ID: 27027434
[TBL] [Abstract][Full Text] [Related]
6. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
7. Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma.
Sun T; Sun BC; Zhao XL; Zhao N; Dong XY; Che N; Yao Z; Ma YM; Gu Q; Zong WK; Liu ZY
Hepatology; 2011 Nov; 54(5):1690-706. PubMed ID: 21748764
[TBL] [Abstract][Full Text] [Related]
8. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
9. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
11. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC
Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372
[TBL] [Abstract][Full Text] [Related]
12. Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling.
Jue C; Lin C; Zhisheng Z; Yayun Q; Feng J; Min Z; Haibo W; Youyang S; Hisamitsu T; Shintaro I; Shiyu G; Yanqing L
Oncotarget; 2017 Jan; 8(2):2501-2513. PubMed ID: 27705934
[TBL] [Abstract][Full Text] [Related]
13. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
[TBL] [Abstract][Full Text] [Related]
14. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells via inducing Twist1 expression.
Zhang XD; Dong XQ; Xu JL; Chen SC; Sun Z
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3061-3068. PubMed ID: 28742200
[TBL] [Abstract][Full Text] [Related]
16. Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma.
Meng J; Chen S; Lei YY; Han JX; Zhong WL; Wang XR; Liu YR; Gao WF; Zhang Q; Tan Q; Liu HJ; Zhou HG; Sun T; Yang C
Oncogene; 2019 Jan; 38(2):228-243. PubMed ID: 30087438
[TBL] [Abstract][Full Text] [Related]
17. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1.
Zhu Y; Qu C; Hong X; Jia Y; Lin M; Luo Y; Lin F; Xie X; Xie X; Huang J; Wu Q; Qiu X; Piao D; Xing Y; Yu T; Lu Y; Huang Q; Yu C; Jin J; Zhang Z
Cell Death Differ; 2019 Jan; 26(2):306-320. PubMed ID: 29748601
[TBL] [Abstract][Full Text] [Related]
18. Myricetin reverses epithelial-endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting PAR1.
Wang M; Ren S; Bi Z; Zhang L; Cui M; Sun R; Bao J; Gao D; Yang B; Li X; Li M; Xiao T; Zhou HG; Yang C
Phytother Res; 2022 Apr; 36(4):1807-1821. PubMed ID: 35229382
[TBL] [Abstract][Full Text] [Related]
19. The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.
Cao Z; Sun B; Zhao X; Zhang Y; Gu Q; Liang X; Dong X; Zhao N
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264434
[TBL] [Abstract][Full Text] [Related]
20. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
